The COVID-19 pandemic has highlighted that new diagnostic technologies are essential for
controlling disease transmission. Here, we develop SHINE (Streamlined Highlighting of …

The widespread transmission and evolution of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) call for rapid nucleic acid diagnostics that are easy to use outside of …

The COVID-19 pandemic has highlighted that new diagnostic technologies are essential for
controlling disease transmission. Here, we develop SHINE (SHERLOCK and HUDSON …

The high disease burden of influenza virus poses a significant threat to human health and
requires better methods to rapidly detect its many circulating species, subtypes, and variants. …

The COVID-19 pandemic, and the recent rise and widespread transmission of SARS-CoV-2
Variants of Concern (VOCs), have demonstrated the need for ubiquitous nucleic acid testing …

The COVID-19 pandemic demonstrated the susceptibility of the United States and the world
to biological threats. These threats can be unintentional, such as the result of zoonotic …

CRISPR-based diagnostics have emerged as a promising tool for fast, accurate, and
portable pathogen detection. There has been rapid progress in areas such as pre-amplification …

The December 2019 outbreak of a novel respiratory virus, SARS-CoV-2, has become an
ongoing global pandemic due in part to the challenge of identifying symptomatic, asymptomatic, …

… of crude samples to inactivate nucleases and viruses, producing a sample that can directly
be combined with other SHERLOCK components including RPA and detection (Arizti-Sanz et …

… One such development could be the elimination of the RNA extraction step, using a
method similar to the optimized HUDSON described by Arizti-Sanz et al., [ 27 ] which permits …